These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 28509609

  • 1. Amyloid- and FDG-PET in sporadic Creutzfeldt-Jakob disease: Correlation with pathological prion protein in neuropathology.
    Matías-Guiu JA, Guerrero-Márquez C, Cabrera-Martín MN, Gómez-Pinedo U, Romeral M, Mayo D, Porta-Etessam J, Moreno-Ramos T, Carreras JL, Matías-Guiu J.
    Prion; 2017 May 04; 11(3):205-213. PubMed ID: 28509609
    [Abstract] [Full Text] [Related]

  • 2. Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) Correlation of Histopathology and MRI in Prion Disease.
    Mente KP, O'Donnell JK, Jones SE, Cohen ML, Thompson NR, Bizzi A, Gambetti P, Safar JG, Appleby BS.
    Alzheimer Dis Assoc Disord; 2017 May 04; 31(1):1-7. PubMed ID: 28121634
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Positron emission tomography with [(18)F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD).
    Henkel K, Zerr I, Hertel A, Gratz KF, Schröter A, Tschampa HJ, Bihl H, Büll U, Grünwald F, Drzezga A, Spitz J, Poser S.
    J Neurol; 2002 Jun 04; 249(6):699-705. PubMed ID: 12111302
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A longitudinal 18F-FDG PET/MRI study in asymptomatic stage of genetic Creutzfeldt-Jakob disease linked to G114V mutation.
    Chu M, Chen Z, Nie B, Liu L, Xie K, Cui Y, Chen K, Rosa-Neto P, Wu L.
    J Neurol; 2022 Nov 04; 269(11):6094-6103. PubMed ID: 35864212
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Bitemporal hypometabolism in Creutzfeldt-Jakob disease measured by positron emission tomography with [18F]-2-fluorodeoxyglucose.
    Friedland RP, Prusiner SB, Jagust WJ, Budinger TF, Davis RL.
    J Comput Assist Tomogr; 1984 Oct 04; 8(5):978-81. PubMed ID: 6381559
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cerebral amyloid angiopathy with co-localization of prion protein and beta-amyloid in an 85-year-old patient with sporadic Creutzfeldt-Jakob disease.
    Paquet C, Privat N, Kaci R, Polivka M, Dupont O, Haïk S, Laplanche JL, Hauw JJ, Gray F.
    Acta Neuropathol; 2008 Nov 04; 116(5):567-73. PubMed ID: 18551298
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of early-phase [18F]-florbetaben PET acquisition in clinical routine cases.
    Daerr S, Brendel M, Zach C, Mille E, Schilling D, Zacherl MJ, Bürger K, Danek A, Pogarell O, Schildan A, Patt M, Barthel H, Sabri O, Bartenstein P, Rominger A.
    Neuroimage Clin; 2017 Nov 04; 14():77-86. PubMed ID: 28138429
    [Abstract] [Full Text] [Related]

  • 17. Three cases of Creutzfeldt-Jakob disease presenting with a predominant dysexecutive syndrome.
    Corriveau-Lecavalier N, Li W, Ramanan VK, Drubach DA, Day GS, Jones DT.
    J Neurol; 2022 Aug 04; 269(8):4222-4228. PubMed ID: 35233692
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Positron emission tomography and histopathology in Creutzfeldt-Jakob disease.
    Goldman S, Laird A, Flament-Durand J, Luxen A, Bidaut LM, Stanus E, Hildebrand J, Przedborski S.
    Neurology; 1993 Sep 04; 43(9):1828-30. PubMed ID: 8414042
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.